Dietary restriction but not rapamycin extends disease onset and survival of the H46R/H48Q mouse model of ALS
暂无分享,去创建一个
F. Muller | H. Remmen | A. Bokov | Vivian Diaz | Arlan Richardson | K. Maslin | A. Bhattacharya | Amanda L. Jernigan
[1] Liang Li,et al. Rapamycin treatment augments motor neuron degeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis , 2011, Autophagy.
[2] R. de Cabo,et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.
[3] Giovanni Manfredi,et al. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS , 2010, Mechanisms of Ageing and Development.
[4] Di Chen,et al. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. , 2010, Cell metabolism.
[5] Arlan Richardson,et al. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. , 2010, The Journal of biological chemistry.
[6] M. Tarnopolsky,et al. Caloric Restriction Shortens Lifespan through an Increase in Lipid Peroxidation, Inflammation and Apoptosis in the G93A Mouse, an Animal Model of ALS , 2010, PloS one.
[7] Chen-Yu Liao,et al. Genetic variation in the murine lifespan response to dietary restriction: from life extension to life shortening , 2010, Aging cell.
[8] B. Kennedy,et al. The TOR pathway comes of age. , 2009, Biochimica et biophysica acta.
[9] B. Kennedy,et al. Ageing: A midlife longevity drug? , 2009, Nature.
[10] Marco Pahor,et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.
[11] Liou Y Sun,et al. Life-span extension in mice by preweaning food restriction and by methionine restriction in middle age. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.
[12] D. Borchelt,et al. MnSOD deficiency has a differential effect on disease progression in two different ALS mutant mouse models , 2008, Muscle & nerve.
[13] R. A. Miller,et al. Design of aging intervention studies: the NIA interventions testing program , 2008, AGE.
[14] M. Tarnopolsky,et al. Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn‐SOD mutant G93A mice , 2006, Muscle & nerve.
[15] D. Rubinsztein,et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. , 2006, Human molecular genetics.
[16] P. Reddy,et al. Neuronal protection by sirtuins in Alzheimer's disease , 2006, Journal of neurochemistry.
[17] M. Tarnopolsky,et al. Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn‐superoxide dismutase mutant G93A mouse , 2005, Muscle & nerve.
[18] A. Bokov,et al. The role of oxidative damage and stress in aging , 2004, Mechanisms of Ageing and Development.
[19] Francesco Scaravilli,et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.
[20] D. Borchelt,et al. Fibrillar Inclusions and Motor Neuron Degeneration in Transgenic Mice Expressing Superoxide Dismutase 1 with a Disrupted Copper-Binding Site , 2002, Neurobiology of Disease.
[21] M. Mattson,et al. No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide dismutase mutant mice , 1999, Brain Research.